These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 34003514)
1. Balloon cells promote immune system activation in focal cortical dysplasia type 2b. Zimmer TS; Broekaart DWM; Luinenburg M; Mijnsbergen C; Anink JJ; Sim NS; Michailidou I; Jansen FE; van Rijen PC; Lee JH; François L; van Eyll J; Dedeurwaerdere S; van Vliet EA; Mühlebner A; Mills JD; Aronica E Neuropathol Appl Neurobiol; 2021 Oct; 47(6):826-839. PubMed ID: 34003514 [TBL] [Abstract][Full Text] [Related]
2. Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis. Lee WS; Baldassari S; Stephenson SEM; Lockhart PJ; Baulac S; Leventer RJ Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163267 [TBL] [Abstract][Full Text] [Related]
3. mTOR pathway activation in focal cortical dysplasia. Kumari K; Sharma MC; Kakkar A; Malgulwar PB; Pathak P; Suri V; Sarkar C; Chandra SP; Faruq M Ann Diagn Pathol; 2020 Jun; 46():151523. PubMed ID: 32325422 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias. Iyer A; Zurolo E; Spliet WG; van Rijen PC; Baayen JC; Gorter JA; Aronica E Epilepsia; 2010 Sep; 51(9):1763-73. PubMed ID: 20345941 [TBL] [Abstract][Full Text] [Related]
5. FCD Type II and mTOR pathway: Evidence for different mechanisms involved in the pathogenesis of dysmorphic neurons. Rossini L; Villani F; Granata T; Tassi L; Tringali G; Cardinale F; Aronica E; Spreafico R; Garbelli R Epilepsy Res; 2017 Jan; 129():146-156. PubMed ID: 28056425 [TBL] [Abstract][Full Text] [Related]
6. Aberrant adenosine signaling in patients with focal cortical dysplasia. Guo M; Zhang J; Wang J; Wang X; Gao Q; Tang C; Deng J; Xiong Z; Kong X; Guan Y; Zhou J; Boison D; Luan G; Li T Mol Neurobiol; 2023 Aug; 60(8):4396-4417. PubMed ID: 37103687 [TBL] [Abstract][Full Text] [Related]
8. Similar PDK1-AKT-mTOR pathway activation in balloon cells and dysmorphic neurons of type II focal cortical dysplasia with refractory epilepsy. Lin YX; Lin K; Kang DZ; Liu XX; Wang XF; Zheng SF; Yu LH; Lin ZY Epilepsy Res; 2015 May; 112():137-49. PubMed ID: 25847349 [TBL] [Abstract][Full Text] [Related]
9. Focal cortical dysplasia pathology: diagnostic difficulty, classification, and utility for pathogenesis. Kapar O; Gurkan ZM; Dolgun M; Sencer A; Gürses C; Bilgic B Neurosurg Focus; 2022 Oct; 53(4):E6. PubMed ID: 36183176 [TBL] [Abstract][Full Text] [Related]
11. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex. Yue J; Zhang C; Shi X; Wei Y; Liu L; Liu S; Yang H Brain Dev; 2019 Nov; 41(10):829-838. PubMed ID: 31495513 [TBL] [Abstract][Full Text] [Related]
13. Activation of extracellular regulated kinase and mechanistic target of rapamycin pathway in focal cortical dysplasia. Patil VV; Guzman M; Carter AN; Rathore G; Yoshor D; Curry D; Wilfong A; Agadi S; Swann JW; Adesina AM; Bhattacharjee MB; Anderson AE Neuropathology; 2016 Apr; 36(2):146-56. PubMed ID: 26381727 [TBL] [Abstract][Full Text] [Related]
14. Somatic Mutations in the MTOR gene cause focal cortical dysplasia type IIb. Nakashima M; Saitsu H; Takei N; Tohyama J; Kato M; Kitaura H; Shiina M; Shirozu H; Masuda H; Watanabe K; Ohba C; Tsurusaki Y; Miyake N; Zheng Y; Sato T; Takebayashi H; Ogata K; Kameyama S; Kakita A; Matsumoto N Ann Neurol; 2015 Sep; 78(3):375-86. PubMed ID: 26018084 [TBL] [Abstract][Full Text] [Related]
15. SLC35A2 somatic variants in drug resistant epilepsy: FCD and MOGHE. Elziny S; Crino PB; Winawer M Neurobiol Dis; 2023 Oct; 187():106299. PubMed ID: 37739137 [TBL] [Abstract][Full Text] [Related]
16. [Activation of mTOR in maldeveloped balloon cells and dysmorphic neurons of type II focal cortical dysplasia]. Lin K; Lin YX; Kang DZ; Ye ZX; Wang XF Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):311-5. PubMed ID: 24004587 [TBL] [Abstract][Full Text] [Related]